The burden of type 2 diabetes in China from 1990 to 2021: A comparative analysis with G20 countries using the global burden of disease study 2021
Authors' conclusion
This study reveals the enormous burden and remarkable control efforts of T2D in China. Comparative analysis emphasizes the importance of tailored public health interventions to address this growing health crisis.
Study context
- Population
- China, 1990–2021, compared with other G20 countries
- Primary endpoint
- Burden of T2D: prevalence, mortality, DALYs, YLLs and YLDs
- Follow-up
- 1990 to 2021
Methodological detailscomparative analysis with G20 countries
- Comparative analysis with G20 countries
Primary result
As reported in the abstract
T2D burden in China
Prevalence rate per 100,000, 1990 to 2021
3519.8 (3138.3-3910.1) to 6055.5 (5510.1-6614.3)
Death rate per 100,000 slightly decreased, 1990 to 2021
9.3 (8.2-10.5) to 8.7 (7.3-10.3)
Disability-adjusted life years (DALYs) rate increased, 1990 to 2021
438.7 (358.5-531.5) to 569.8 (435.4-734.2)
Further findings
Comparison with G20 countries
- China ranked high in prevalence but had relatively better mortality outcomes in older age groups
Original publication
The burden of type 2 diabetes in China from 1990 to 2021: A comparative analysis with G20 countries using the global burden of disease study 2021. Diabetes Res Clin Pract. Published 16 April 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →